Literature DB >> 9820941

Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization.

C Cursiefen1, M Küchle, G O Naumann.   

Abstract

PURPOSE: Angiogenesis in corneal diseases can necessitate corneal transplantation and induce graft rejection. The aim of this study was to find out the histopathologic prevalence of angiogenesis in human corneas removed during keratoplasty, to establish the histopathologic diagnoses most commonly associated with angiogenesis, and to evaluate the anatomic location of new corneal vessels.
METHODS: Corneal buttons (2,557) after keratoplasty were sent to and analyzed in our ophthalmopathology laboratory between 1992 and 1996. Of these, 1,278 full-thickness and lamellar corneal buttons were randomly retrieved and evaluated in this study.
RESULTS: Of 1,278 human corneal buttons obtained by keratoplasty, 254 (19.9%) showed angiogenesis. Associated histopathologic diagnoses were (a) scarring after keratitis (109, 45.4%); (b) graft rejection and insufficiency (73, 30.4%); (c) acute necrotizing ulcerative keratitis (30, 12.5%); and (d) scarring after mechanical or chemical injuries (28, 11.7%). Histopathologically, new vessels were usually associated with corneal edema or inflammatory cells or both (76%). The most common locations of new vessels were the upper and middle third of the corneal stroma. Only 11% of new vessels were located solely in the deep stromal layers.
CONCLUSION: Angiogenesis is a common histopathologic feature of corneal diseases leading to corneal transplantation and was found in 19.9% of excised human corneal buttons. Systemic or topical antiangiogenic therapy could reduce the need for corneal transplantation and retransplantation.

Entities:  

Mesh:

Year:  1998        PMID: 9820941     DOI: 10.1097/00003226-199811000-00008

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  28 in total

1.  Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation.

Authors:  C Cursiefen; C Hofmann-Rummelt; M Küchle; U Schlötzer-Schrehardt
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 2.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 3.  Clinical correlates of common corneal neovascular diseases: a literature review.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Hamdy Salem; Ahmed E Elkhanany; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

4.  Anti-neovascular effect of chondrocyte-derived extracellular matrix on corneal alkaline burns in rabbits.

Authors:  Hye Sook Lee; Ji Hyun Lee; Chae Eun Kim; Jae Wook Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-01       Impact factor: 3.117

5.  Hemangiogenesis and lymphangiogenesis in corneal pathology.

Authors:  Makambo Tshionyi; Elizabeth Shay; Elisa Lunde; Amy Lin; Kyu-Yeon Han; Sandeep Jain; Jin-Hong Chang; Dimitri T Azar
Journal:  Cornea       Date:  2012-01       Impact factor: 2.651

6.  Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival.

Authors:  Romina Fasciani; Luigi Mosca; Maria Ilaria Giannico; Simone Antonio Ambrogio; Emilio Balestrazzi
Journal:  Int Ophthalmol       Date:  2014-04-09       Impact factor: 2.031

7.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 8.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

9.  IFN-gamma acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1.

Authors:  Vijay K Kommineni; Chandrasekharam N Nagineni; Abitha William; Barbara Detrick; John J Hooks
Journal:  Biochem Biophys Res Commun       Date:  2008-07-17       Impact factor: 3.575

10.  Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.

Authors:  Mohammad H Dastjerdi; Khalid M Al-Arfaj; Nambi Nallasamy; Pedram Hamrah; Ula V Jurkunas; Roberto Pineda; Deborah Pavan-Langston; Reza Dana
Journal:  Arch Ophthalmol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.